More collaboration is needed about benefits of new genetic screening tests

doi:10.1136/bmj.317.7156.471a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Brendan O'Connor, Consultant in public health medicine

East Sussex, Brighton and Hove Health Authority, Lewes, East Sussex BN7 2PB

EDITOR—Gill and Richards request a full and rigorous assessment of the benefits and costs of introducing new genetic screening tests.1 They point out the need for collaboration between geneticists, public health specialists, and primary care teams and emphasise the importance of the general public.

A spot analysis of data available for East Sussex, Brighton and Hove Health Authority for the current financial year (1997-8) from an eligible general population …